{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:06:06Z","timestamp":1777467966360,"version":"3.51.4"},"reference-count":27,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BD"],"published-print":{"date-parts":[[2023,1,10]]},"abstract":"<jats:p>BACKGROUND: In breast cancer patients, there is an elevated risk of developing osteoporosis during treatment which should be addressed by optimizing 25(OH) levels. OBJECTIVE: The aim was to assess the prescription, information and physician-patient communication on vitamin D and bone density in Germany. METHODS: We developed a standardized questionnaire concerning bone density measurement, vitamin D (blood level testing, prescription), information and communication regarding vitamin D. The questionnaire was distributed at the annual meeting of all group leaders of the Women\u2019s Cancer Support Association to all participants. RESULTS: Overall, 224 participants completed the questionnaire; 77.7% reported having had at least one bone density measurement test. The number was 84.4% in patients treated with aromatase inhibitor and 43.7% reported that their bone density was too low. In total, 51.3% patients reported at least one vitamin D blood test and 45.1% reported that vitamin D had been primarily addressed by a physician. As many as 74.1% of those reporting a test result had a deficiency; 91.6% of those with a low level got a prescription and 28.4% took vitamin D autonomously. CONCLUSIONS: The awareness on risk of osteoporosis, prevention, early diagnosis and treatment are insufficiently addressed in a patient group with high risk of osteoporosis. More attention should be paid to the phenomenon of vitamin D deficiency or insufficiency in routine care.<\/jats:p>","DOI":"10.3233\/bd-210070","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T12:02:35Z","timestamp":1673611355000},"page":"503-511","source":"Crossref","is-referenced-by-count":2,"title":["Vitamin D during treatment for breast cancer \u2013 the perspective of active self-help group leaders"],"prefix":"10.1177","volume":"41","author":[{"given":"Ralph","family":"Muecke","sequence":"first","affiliation":[{"name":", , Ruhr University Bochum, , Germany"},{"name":"Radiotherapy RheinMainNahe, , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Dubois","sequence":"additional","affiliation":[{"name":", Jena University Hospital, , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Micke","sequence":"additional","affiliation":[{"name":", , , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Keinki","sequence":"additional","affiliation":[{"name":", Jena University Hospital, , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Huebner","sequence":"additional","affiliation":[{"name":", Jena University Hospital, , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/BD-210070_ref1","unstructured":"Leitlinie des Dachverbands der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften e. V. Prophylaxe, Diagnostik und Therapie der Osteoporose bei postmenopausalen Frauen und bei M\u00e4nnern (Prophylaxis, diagnosis and therapy of osteoporosis in postmenopausal Women and Men), AWMF-Register-Nr.: 183\/001. 2017."},{"key":"10.3233\/BD-210070_ref2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/1759720X18759291","article-title":"Aromatase inhibitors are associated with a higher fracture risk than tamoxifen: A systematic review and meta-analysis","volume":"10","author":"Tseng","year":"2018","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.3233\/BD-210070_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103114"},{"key":"10.3233\/BD-210070_ref4","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms (S3 guideline for early detection, diagnosis, therapy and follow-up care of breast cancer), Version 4.4, 2021, AWMF Registernummer: 032-045OL. n.d."},{"key":"10.3233\/BD-210070_ref5","unstructured":"Kommission Mamma der, Arbeitsgemeinschaft Gyn\u00e4kologische Onkologie e.V. (AGO) f\u00fcr Patientinnen, Patienten, Angeh\u00f6rige und Interessierte. Brustkrebs\u2013Patientenratgeber zu den AGO-Empfehlungen 2019 (Breast Cancer\u2013Patient\u2019s Guide to the AGO Recommendations 2019. M\u00fcnchen: 2019."},{"key":"10.3233\/BD-210070_ref6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.maturitas.2010.03.012","article-title":"Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer","volume":"66","author":"Nogues","year":"2010","journal-title":"Maturitas"},{"key":"10.3233\/BD-210070_ref7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10552-013-0158-4","article-title":"Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors","volume":"24","author":"Villase\u00f1or","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.3233\/BD-210070_ref8","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10549-015-3355-x","article-title":"Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer","volume":"150","author":"Lohmann","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-210070_ref9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.critrevonc.2013.07.002","article-title":"Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy","volume":"88","author":"Datta","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.3233\/BD-210070_ref10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s11914-007-0027-8","article-title":"Cancer-associated bone disease","volume":"5","author":"Brown","year":"2007","journal-title":"Curr Osteoporos Rep"},{"key":"10.3233\/BD-210070_ref11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1158\/1078-0432.CCR-10-1595","article-title":"Cancer therapy associated bone loss: Implications for hip fractures in mid-life women with breast cancer","volume":"17","author":"Edwards","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.3233\/BD-210070_ref12","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1359\/jbmr.060301","article-title":"Impact of recent fracture on health-related quality of life in postmenopausal women","volume":"21","author":"Brenneman","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.3233\/BD-210070_ref13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00198-008-0761-5","article-title":"Sequential change in quality of life for patients with incident clinical fractures: A prospective study","volume":"20","author":"Hagino","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.3233\/BD-210070_ref14","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s00198-004-1622-5","article-title":"Health-related quality of life after osteoporotic fractures","volume":"15","author":"Hallberg","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.3233\/BD-210070_ref15","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00198-009-0920-3","article-title":"Excess mortality following hip fracture: A systematic epidemiological review","volume":"20","author":"Abrahamsen","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.3233\/BD-210070_ref16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1471-2474-12-105","article-title":"Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study","volume":"12","author":"Panula","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"10.3233\/BD-210070_ref17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3945\/ajcn.2010.30009","article-title":"Vitamin D and breast cancer recurrence in the Women\u2019s Healthy Eating and Living (WHEL) Study","volume":"93","author":"Jacobs","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.3233\/BD-210070_ref18","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/bcr2920","article-title":"Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study","volume":"13","author":"Vrieling","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.3233\/BD-210070_ref19","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1634\/theoncologist.2011-0098","article-title":"Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: A systematic review","volume":"16","author":"Buttigliero","year":"2011","journal-title":"Oncologist"},{"key":"10.3233\/BD-210070_ref20","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.ejca.2014.02.006","article-title":"Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies","volume":"50","author":"Maalmi","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.3233\/BD-210070_ref21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5414\/TEX01556","article-title":"for cancer patients in routine health care \u2014 the patients\u2019 perspective","volume":"35","author":"Kirton","year":"2018","journal-title":"Trace Elements and Electrolytes"},{"key":"10.3233\/BD-210070_ref23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10549-011-1644-6","article-title":"Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): A phase II, double-blind, placebo-controlled, randomized trial","volume":"129","author":"Rastelli","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-210070_ref24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10549-011-1415-4","article-title":"The effect of various vitamin D supplementation regimens in breast cancer patients","volume":"127","author":"Peppone","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-210070_ref26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10549-016-3710-6","article-title":"Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS)","volume":"155","author":"Shapiro","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-210070_ref27","doi-asserted-by":"publisher","first-page":"e0152441","DOI":"10.1371\/journal.pone.0152441","article-title":"Serum 25-Hydroxyvitamin D Concentrations \u226540 ng\/ml are associated with >65% lower cancer risk: Pooled analysis of randomized trial and prospective cohort study","volume":"11","author":"McDonnell","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/BD-210070_ref28","doi-asserted-by":"publisher","first-page":"e4469","DOI":"10.17795\/ijcp-4469","article-title":"The correlation of plasma 25-Hydroxyvitamin D deficiency with risk of breast neoplasms: A systematic review","volume":"9","author":"Shekarriz-Foumani","year":"2016","journal-title":"Iran J Cancer Prev"},{"key":"10.3233\/BD-210070_ref29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s10549-012-2013-9","article-title":"Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study","volume":"133","author":"Prieto-Alhambra","year":"2012","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/BD-210070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:32:23Z","timestamp":1777383143000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/BD-210070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":27,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/bd-210070","relation":{},"ISSN":["0888-6008","1558-1551"],"issn-type":[{"value":"0888-6008","type":"print"},{"value":"1558-1551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]}}}